JP2025511232A5 - - Google Patents
Info
- Publication number
- JP2025511232A5 JP2025511232A5 JP2024558117A JP2024558117A JP2025511232A5 JP 2025511232 A5 JP2025511232 A5 JP 2025511232A5 JP 2024558117 A JP2024558117 A JP 2024558117A JP 2024558117 A JP2024558117 A JP 2024558117A JP 2025511232 A5 JP2025511232 A5 JP 2025511232A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- particles
- mixture
- api
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT117893 | 2022-03-31 | ||
| PT11789322 | 2022-03-31 | ||
| PCT/GB2023/050841 WO2023187393A1 (en) | 2022-03-31 | 2023-03-30 | Inhalation composite and carrier based formulation combination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511232A JP2025511232A (ja) | 2025-04-15 |
| JP2025511232A5 true JP2025511232A5 (https=) | 2026-04-07 |
Family
ID=86007693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024558117A Pending JP2025511232A (ja) | 2022-03-31 | 2023-03-30 | 吸入複合体及び担体ベースの製剤の組合せ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250205153A1 (https=) |
| EP (1) | EP4499040A1 (https=) |
| JP (1) | JP2025511232A (https=) |
| CN (1) | CN119278026A (https=) |
| WO (1) | WO2023187393A1 (https=) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2231968A1 (en) | 1998-03-11 | 1999-09-11 | Smoke-Stop, A Partnership Consisting Of Art Slutsky | Method of producing a nicotine medicament |
| CA2265198C (en) | 1998-03-11 | 2009-01-27 | Zamel, Noe | Method of producing a nicotine medicament and a medicament made by the method |
| AU772798B2 (en) | 1999-04-21 | 2004-05-06 | 1355540 Ontario Inc. | Formulations for detecting asthma |
| JP5698423B2 (ja) | 2000-06-27 | 2015-04-08 | ベクトゥラ・リミテッド | 医薬組成物で使用するための粒子の製造法 |
| ES2474199T3 (es) | 2000-11-30 | 2014-07-08 | Vectura Limited | Composiciones farmacéuticas para inhalaci�n |
| JP2006522634A (ja) | 2003-04-14 | 2006-10-05 | ベクトゥラ・リミテッド | 投与効率を向上させるデバイス及び製薬組成 |
| KR20060015316A (ko) | 2003-05-28 | 2006-02-16 | 넥타르 테라퓨틱스 | 아미노산 및/또는 인지질로 부분 또는 완전 코팅된수불용성 활성제 미립자의 제조를 위한 알코올성 수용액의분무 건조법 |
| GB0321607D0 (en) | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| EP1925295A1 (de) | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stabile Pulverformulierung enthaltend ein Anticholinergikum |
| EP2821061B1 (en) | 2013-07-01 | 2017-12-20 | Arven Ilac Sanayi Ve Ticaret A.S. | Novel inhalation formulations |
| PT109030B (pt) * | 2015-12-15 | 2019-09-25 | Hovione Farmaciência, S.A. | Preparação de partículas inaláveis de zafirlucaste |
| CN111358773B (zh) * | 2020-04-10 | 2021-03-30 | 广州南鑫药业有限公司 | 一种帕拉米韦干粉吸入剂及其制备方法 |
| PT3962455T (pt) | 2020-05-18 | 2022-10-13 | Orexo Ab | Nova composição farmacêutica para entrega de fármacos |
-
2023
- 2023-03-30 CN CN202380036806.3A patent/CN119278026A/zh active Pending
- 2023-03-30 US US18/852,256 patent/US20250205153A1/en active Pending
- 2023-03-30 EP EP23717216.8A patent/EP4499040A1/en active Pending
- 2023-03-30 JP JP2024558117A patent/JP2025511232A/ja active Pending
- 2023-03-30 WO PCT/GB2023/050841 patent/WO2023187393A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2767064C2 (ru) | Никотиносодержащие частицы и композиции | |
| Chang et al. | Advancements in particle engineering for inhalation delivery of small molecules and biotherapeutics | |
| US10376466B2 (en) | Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent | |
| ES2708218T3 (es) | Método y formulación para inhalación | |
| Lin et al. | Powder production and particle engineering for dry powder inhaler formulations | |
| CN103717231B (zh) | 干粉万古霉素组合物以及相关方法 | |
| Yang et al. | Recent developments in dry powder inhalation (DPI) formulations for lung-targeted drug delivery | |
| ES2389156T3 (es) | Administración pulmonar de levodopa | |
| US20060147520A1 (en) | Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation | |
| HUT77777A (hu) | Szilárd vivőrendszerek molekulák kontrollált kibocsátására és eljárások a vivőrendszerek előállítására | |
| KR20210134805A (ko) | 열-안정성 건조 분말 약제학적 조성물 및 방법 | |
| JP2022532431A5 (https=) | ||
| JP2018514564A5 (https=) | ||
| TW200829285A (en) | Method for mixing powders | |
| JP2025511232A5 (https=) | ||
| JP2017523189A (ja) | 吸入用の乾燥粉末製剤 | |
| RU2847582C2 (ru) | Никотиносодержащие частицы и композиции | |
| Adhikari et al. | Co-amorphization: a formulation strategy for amorphous high dose dry powder to treat lung infections | |
| Pannonhalminé Csóka et al. | Pulmonary drug delivery systems of antibiotics for the treatment of respiratory tract infections | |
| JP2024510564A5 (https=) | ||
| Csóka et al. | Pulmonary drug delivery systems of antibiotics for the treatment of respiratory tract infections: Pulmonary drug delivery systems of antibiotics | |
| KR20180052566A (ko) | 폐 전달용 트립탄 분말 | |
| Rossi et al. | Inhalable N-acetylcysteine dry powder formulations as potential adjuvant treatment for COVID-19 |